A Study to Evaluate Efficacy and Safety of GW906 in Patients With Essential Hypertension
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 319 participants.
Also called NCT07835971
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 319 participants
- Registry
-
NCT07835971
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07835971. Randomized; quadruple masking; primary purpose treatment. Start 2025-12-24 (actual); primary completion 2026-09-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate Efficacy and Safety of GW906 in Patients With Essential Hypertension
- Condition
- Hypertension
- Intervention (Drug)
- GW906
- Intervention (Drug)
- Placebo
- Lead sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
Record details
- Record id
cardio:ct-nct07835971- Content hash
47ee9c2c5af446ce501f66295a1872b6ce0ea8d671d08900fbb17be706108b52